% $ biblatex auxiliary file $
% $ biblatex bbl format version 3.1 $
% Do not modify the above lines!
%
% This is an auxiliary file used by the 'biblatex' package.
% This file may safely be deleted. It will be recreated as
% required.
%
\begingroup
\makeatletter
\@ifundefined{ver@biblatex.sty}
  {\@latex@error
     {Missing 'biblatex' package}
     {The bibliography requires the 'biblatex' package.}
      \aftergroup\endinput}
  {}
\endgroup

\datalist[entry]{none/global//global/global}
  \entry{stransky_mutational_2011}{article}{}
    \name{author}{39}{}{%
      {{hash=SN}{%
         family={Stransky},
         familyi={S\bibinitperiod},
         given={Nicolas},
         giveni={N\bibinitperiod},
      }}%
      {{hash=EAM}{%
         family={Egloff},
         familyi={E\bibinitperiod},
         given={Ann\bibnamedelima Marie},
         giveni={A\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=TAD}{%
         family={Tward},
         familyi={T\bibinitperiod},
         given={Aaron\bibnamedelima D.},
         giveni={A\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=KAD}{%
         family={Kostic},
         familyi={K\bibinitperiod},
         given={Aleksandar\bibnamedelima D.},
         giveni={A\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=CK}{%
         family={Cibulskis},
         familyi={C\bibinitperiod},
         given={Kristian},
         giveni={K\bibinitperiod},
      }}%
      {{hash=SA}{%
         family={Sivachenko},
         familyi={S\bibinitperiod},
         given={Andrey},
         giveni={A\bibinitperiod},
      }}%
      {{hash=KGV}{%
         family={Kryukov},
         familyi={K\bibinitperiod},
         given={Gregory\bibnamedelima V.},
         giveni={G\bibinitperiod\bibinitdelim V\bibinitperiod},
      }}%
      {{hash=LM}{%
         family={Lawrence},
         familyi={L\bibinitperiod},
         given={Michael},
         giveni={M\bibinitperiod},
      }}%
      {{hash=SC}{%
         family={Sougnez},
         familyi={S\bibinitperiod},
         given={Carrie},
         giveni={C\bibinitperiod},
      }}%
      {{hash=MA}{%
         family={{McKenna}},
         familyi={M\bibinitperiod},
         given={Aaron},
         giveni={A\bibinitperiod},
      }}%
      {{hash=SE}{%
         family={Shefler},
         familyi={S\bibinitperiod},
         given={Erica},
         giveni={E\bibinitperiod},
      }}%
      {{hash=RAH}{%
         family={Ramos},
         familyi={R\bibinitperiod},
         given={Alex\bibnamedelima H.},
         giveni={A\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=SP}{%
         family={Stojanov},
         familyi={S\bibinitperiod},
         given={Petar},
         giveni={P\bibinitperiod},
      }}%
      {{hash=CSL}{%
         family={Carter},
         familyi={C\bibinitperiod},
         given={Scott\bibnamedelima L.},
         giveni={S\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=VD}{%
         family={Voet},
         familyi={V\bibinitperiod},
         given={Douglas},
         giveni={D\bibinitperiod},
      }}%
      {{hash=CML}{%
         family={Cortés},
         familyi={C\bibinitperiod},
         given={Maria\bibnamedelima L},
         giveni={M\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=AD}{%
         family={Auclair},
         familyi={A\bibinitperiod},
         given={Daniel},
         giveni={D\bibinitperiod},
      }}%
      {{hash=BMF}{%
         family={Berger},
         familyi={B\bibinitperiod},
         given={Michael\bibnamedelima F.},
         giveni={M\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=SG}{%
         family={Saksena},
         familyi={S\bibinitperiod},
         given={Gordon},
         giveni={G\bibinitperiod},
      }}%
      {{hash=GC}{%
         family={Guiducci},
         familyi={G\bibinitperiod},
         given={Candace},
         giveni={C\bibinitperiod},
      }}%
      {{hash=OR}{%
         family={Onofrio},
         familyi={O\bibinitperiod},
         given={Robert},
         giveni={R\bibinitperiod},
      }}%
      {{hash=PM}{%
         family={Parkin},
         familyi={P\bibinitperiod},
         given={Melissa},
         giveni={M\bibinitperiod},
      }}%
      {{hash=RM}{%
         family={Romkes},
         familyi={R\bibinitperiod},
         given={Marjorie},
         giveni={M\bibinitperiod},
      }}%
      {{hash=WJL}{%
         family={Weissfeld},
         familyi={W\bibinitperiod},
         given={Joel\bibnamedelima L.},
         giveni={J\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=SRR}{%
         family={Seethala},
         familyi={S\bibinitperiod},
         given={Raja\bibnamedelima R.},
         giveni={R\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=WL}{%
         family={Wang},
         familyi={W\bibinitperiod},
         given={Lin},
         giveni={L\bibinitperiod},
      }}%
      {{hash=REC}{%
         family={Rangel-Escareño},
         familyi={R\bibinithyphendelim E\bibinitperiod},
         given={Claudia},
         giveni={C\bibinitperiod},
      }}%
      {{hash=FLJC}{%
         family={Fernandez-Lopez},
         familyi={F\bibinithyphendelim L\bibinitperiod},
         given={Juan\bibnamedelima Carlos},
         giveni={J\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=HMA}{%
         family={Hidalgo-Miranda},
         familyi={H\bibinithyphendelim M\bibinitperiod},
         given={Alfredo},
         giveni={A\bibinitperiod},
      }}%
      {{hash=MZJ}{%
         family={Melendez-Zajgla},
         familyi={M\bibinithyphendelim Z\bibinitperiod},
         given={Jorge},
         giveni={J\bibinitperiod},
      }}%
      {{hash=WW}{%
         family={Winckler},
         familyi={W\bibinitperiod},
         given={Wendy},
         giveni={W\bibinitperiod},
      }}%
      {{hash=AK}{%
         family={Ardlie},
         familyi={A\bibinitperiod},
         given={Kristin},
         giveni={K\bibinitperiod},
      }}%
      {{hash=GSB}{%
         family={Gabriel},
         familyi={G\bibinitperiod},
         given={Stacey\bibnamedelima B.},
         giveni={S\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=MM}{%
         family={Meyerson},
         familyi={M\bibinitperiod},
         given={Matthew},
         giveni={M\bibinitperiod},
      }}%
      {{hash=LES}{%
         family={Lander},
         familyi={L\bibinitperiod},
         given={Eric\bibnamedelima S.},
         giveni={E\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=GG}{%
         family={Getz},
         familyi={G\bibinitperiod},
         given={Gad},
         giveni={G\bibinitperiod},
      }}%
      {{hash=GTR}{%
         family={Golub},
         familyi={G\bibinitperiod},
         given={Todd\bibnamedelima R.},
         giveni={T\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=GLA}{%
         family={Garraway},
         familyi={G\bibinitperiod},
         given={Levi\bibnamedelima A.},
         giveni={L\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=GJR}{%
         family={Grandis},
         familyi={G\bibinitperiod},
         given={Jennifer\bibnamedelima R.},
         giveni={J\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
    }
    \strng{namehash}{SNEAMTAD+1}
  \strng{fullhash}{SNEAMTADKADCKSAKGVLMSCMASERAHSPCSLVDCMLADBMFSGGCORPMRMWJLSRRWLRECFLJCHMAMZJWWAKGSBMMLESGGGTRGLAGJR1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Head and neck squamous cell carcinoma ({HNSCC}) is a common, morbid, and
  frequently lethal malignancy. To uncover its mutational spectrum, we analyzed
  whole-exome sequencing data from 74 tumor-normal pairs. The majority
  exhibited a mutational profile consistent with tobacco exposure; human
  papilloma virus was detectable by sequencing of {DNA} from infected tumors.
  In addition to identifying previously known {HNSCC} genes ({TP}53, {CDKN}2A,
  {PTEN}, {PIK}3CA, and {HRAS}), the analysis revealed many genes not
  previously implicated in this malignancy. At least 30\% of cases harbored
  mutations in genes that regulate squamous differentiation (e.g., {NOTCH}1,
  {IRF}6, and {TP}63), implicating its dysregulation as a major driver of
  {HNSCC} carcinogenesis. More generally, the results indicate the ability of
  large-scale sequencing to reveal fundamental tumorigenic mechanisms.%
    }
    \verb{doi}
    \verb 10.1126/science.1208130
    \endverb
    \field{issn}{0036-8075}
    \field{number}{6046}
    \field{pages}{1157\bibrangedash 1160}
    \field{shortjournal}{Science}
    \field{title}{The Mutational Landscape of Head and Neck Squamous Cell
  Carcinoma}
    \verb{url}
    \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415217/
    \endverb
    \field{volume}{333}
    \verb{file}
    \verb PubMed Central Full Text PDF:C\:\\Users\\PatelAL\\Zotero\\storage\\28
    \verb L93KLM\\Stransky et al. - 2011 - The Mutational Landscape of Head and
    \verb  Neck Squamous.pdf:application/pdf
    \endverb
    \field{journaltitle}{Science (New York, N.Y.)}
    \field{day}{26}
    \field{month}{08}
    \field{year}{2011}
    \field{urlday}{20}
    \field{urlmonth}{07}
    \field{urlyear}{2020}
  \endentry

  \entry{cancer_research_uk_head_2017}{online}{}
    \name{author}{1}{}{%
      {{hash=UCR}{%
         family={{UK}},
         familyi={U\bibinitperiod},
         given={Cancer\bibnamedelima Research},
         giveni={C\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
    }
    \strng{namehash}{UCR1}
    \strng{fullhash}{UCR1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    The latest Head and neck cancers statistics for the {UK} for Health
  Professionals. See data for incidence, mortality, survival, risk and more.%
    }
    \field{note}{Library Catalog: www.cancerresearchuk.org}
    \field{titleaddon}{Cancer Research {UK}}
    \field{title}{Head and neck cancers statistics}
    \verb{url}
    \verb https://www.cancerresearchuk.org/health-professional/cancer-statistic
    \verb s/statistics-by-cancer-type/head-and-neck-cancers
    \endverb
    \field{langid}{english}
    \verb{file}
    \verb Snapshot:C\:\\Users\\PatelAL\\Zotero\\storage\\JPKNM8NW\\head-and-nec
    \verb k-cancers.html:text/html
    \endverb
    \field{day}{08}
    \field{month}{02}
    \field{year}{2017}
    \field{urlday}{21}
    \field{urlmonth}{07}
    \field{urlyear}{2020}
  \endentry

  \entry{round_radiotherapy_2013}{article}{}
    \name{author}{7}{}{%
      {{hash=RCE}{%
         family={Round},
         familyi={R\bibinitperiod},
         given={C.\bibnamedelima E.},
         giveni={C\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=WMV}{%
         family={Williams},
         familyi={W\bibinitperiod},
         given={M.\bibnamedelima V.},
         giveni={M\bibinitperiod\bibinitdelim V\bibinitperiod},
      }}%
      {{hash=MT}{%
         family={Mee},
         familyi={M\bibinitperiod},
         given={T.},
         giveni={T\bibinitperiod},
      }}%
      {{hash=KNF}{%
         family={Kirkby},
         familyi={K\bibinitperiod},
         given={N.\bibnamedelima F.},
         giveni={N\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=CT}{%
         family={Cooper},
         familyi={C\bibinitperiod},
         given={T.},
         giveni={T\bibinitperiod},
      }}%
      {{hash=HP}{%
         family={Hoskin},
         familyi={H\bibinitperiod},
         given={P.},
         giveni={P\bibinitperiod},
      }}%
      {{hash=JR}{%
         family={Jena},
         familyi={J\bibinitperiod},
         given={R.},
         giveni={R\bibinitperiod},
      }}%
    }
    \keyw{Access, capacity, demand, fractionation, modelling, radiotherapy}
    \strng{namehash}{RCEWMVMT+1}
    \strng{fullhash}{RCEWMVMTKNFCTHPJR1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Aims This paper compares the predictions of radiotherapy demand for England
  from the Malthus model with those from the earlier National Radiotherapy
  Advisory Group ({NRAG}) model, from the international literature and also
  with observed radiotherapy usage in England as a whole as recorded in the
  English radiotherapy dataset ({RTDS}). Materials and methods We reviewed the
  evidence base for radiotherapy for each type and stage of cancer using
  national and international guidelines, meta-analyses, systematic reviews and
  key clinical trials. Twenty-two decision trees were constructed and
  radiotherapy demand was calculated using English cancer incidence data for
  2007, 2008 and 2009, accurate to the Primary Care Trust ({PCT}) level
  (population 91 500–1 282 384). The stage at presentation was obtained
  from English cancer registry data. In predictive mode, the model can take
  account of changes in cancer incidence as the population grows and ages.
  Results The Malthus model indicates reduced indications for radiotherapy,
  principally for lung cancer and rarer tumours. Our estimate of the proportion
  of patients who should receive radiotherapy at some stage of their illness is
  40.6\%. This is lower than previous estimates of about 50\%. Nevertheless,
  the overall estimate of demand in terms of attendances is similar for the
  {NRAG} and Malthus models. The latter models that 48 827 attendances should
  have been delivered per million population in 2011. National data from {RTDS}
  show 32 071 attendances per million in 2011. A 50\% increase in activity
  would be required to match estimated demand. This underprovision extends
  across all cancers and represents reduced access and the use of dose
  fractionation at odds with international norms of evidence-based practice. By
  2016, demand is predicted to grow to about 55 206 attendances per million
  and by 2020 to 60 057. Discussion Services have increased their activity by
  14\% between 2006 and 2011, but estimated demand has increased by 11\%.
  Access remains low and English radiotherapy dose fractionation still does not
  comply with international evidence-based practice.%
    }
    \verb{doi}
    \verb 10.1016/j.clon.2013.05.005
    \endverb
    \field{issn}{0936-6555}
    \field{number}{9}
    \field{pages}{522\bibrangedash 530}
    \field{shortjournal}{Clinical Oncology}
    \field{title}{Radiotherapy Demand and Activity in England 2006–2020}
    \verb{url}
    \verb http://www.sciencedirect.com/science/article/pii/S0936655513002343
    \endverb
    \field{volume}{25}
    \field{langid}{english}
    \verb{file}
    \verb ScienceDirect Snapshot:C\:\\Users\\PatelAL\\Zotero\\storage\\WZBWGA9P
    \verb \\S0936655513002343.html:text/html;ScienceDirect Full Text PDF:C\:\\U
    \verb sers\\PatelAL\\Zotero\\storage\\EJJXI7S9\\Round et al. - 2013 - Radio
    \verb therapy Demand and Activity in England 2006–2.pdf:application/pdf
    \endverb
    \field{journaltitle}{Clinical Oncology}
    \field{day}{01}
    \field{month}{09}
    \field{year}{2013}
    \field{urlday}{21}
    \field{urlmonth}{07}
    \field{urlyear}{2020}
  \endentry

  \entry{cognetti_head_2008}{article}{}
    \name{author}{3}{}{%
      {{hash=CDM}{%
         family={Cognetti},
         familyi={C\bibinitperiod},
         given={David\bibnamedelima M.},
         giveni={D\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=WRS}{%
         family={Weber},
         familyi={W\bibinitperiod},
         given={Randal\bibnamedelima S.},
         giveni={R\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=LSY}{%
         family={Lai},
         familyi={L\bibinitperiod},
         given={Stephen\bibnamedelima Y.},
         giveni={S\bibinitperiod\bibinitdelim Y\bibinitperiod},
      }}%
    }
    \strng{namehash}{CDMWRSLSY1}
    \strng{fullhash}{CDMWRSLSY1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{shorttitle}
    \field{abstract}{%
    Since the inception of this journal in 1948, the understanding of etiologic
  factors that contribute to and the treatment of head and neck cancer has
  evolved dramatically. Advances in surgery, radiation therapy, and
  chemotherapy have improved locoregional control, survival, and quality of
  life. The outcomes of these treatment modalities have shifted the focus of
  curative efforts from radical ablation to preservation and restoration of
  function. This evolution has been documented in the pages of Cancer for the
  past 6 decades. This review focuses on the evolution of treatment approaches
  for head and neck cancer and future directions while recognizing the historic
  contributions recorded within this journal.%
    }
    \verb{doi}
    \verb 10.1002/cncr.23654
    \endverb
    \field{issn}{0008-543X}
    \field{number}{7}
    \field{pages}{1911\bibrangedash 1932}
    \field{shortjournal}{Cancer}
    \field{shorttitle}{Head and Neck Cancer}
    \field{title}{Head and Neck Cancer: An Evolving Treatment Paradigm}
    \verb{url}
    \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751600/
    \endverb
    \field{volume}{113}
    \verb{file}
    \verb PubMed Central Full Text PDF:C\:\\Users\\PatelAL\\Zotero\\storage\\4C
    \verb QHWE9S\\Cognetti et al. - 2008 - Head and Neck Cancer An Evolving Tre
    \verb atment Paradi.pdf:application/pdf
    \endverb
    \field{journaltitle}{Cancer}
    \field{day}{01}
    \field{month}{10}
    \field{year}{2008}
    \field{urlday}{21}
    \field{urlmonth}{07}
    \field{urlyear}{2020}
  \endentry

  \entry{pignon_chemotherapy_2000}{article}{}
    \name{author}{4}{}{%
      {{hash=PJ}{%
         family={Pignon},
         familyi={P\bibinitperiod},
         given={{JP}},
         giveni={J\bibinitperiod},
      }}%
      {{hash=BJ}{%
         family={Bourhis},
         familyi={B\bibinitperiod},
         given={J},
         giveni={J},
      }}%
      {{hash=DC}{%
         family={Domenge},
         familyi={D\bibinitperiod},
         given={C},
         giveni={C},
      }}%
      {{hash=DL}{%
         family={Designé},
         familyi={D\bibinitperiod},
         given={L},
         giveni={L},
      }}%
    }
    \strng{namehash}{PJBJDC+1}
    \strng{fullhash}{PJBJDCDL1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{shorttitle}
    \field{abstract}{%
    Background Despite more than 70 randomised trials, the effect of
  chemotherapy on non-metastatic head and neck squamous-cell carcinoma remains
  uncertain. We did three meta-analyses of the impact of survival on
  chemotherapy added to locoregional treatment. Methods We updated data on all
  patients in randomised trials between 1965 and 1993. We included patients
  with carcinoma of the oropharynx, oral cavity, larynx, or hypopharynx.
  Findings The main meta-analysis of 63 trials (10 741 patients) of
  locoregional treatment with or without chemotherapy yielded a pooled hazard
  ratio of death of 0·90 (95\% {CI} 0·85–0·94, p{\textless}0·0001),
  corresponding to an absolute survival benefit of 4\% at 2 and 5 years in
  favour of chemotherapy. There was no significant benefit associated with
  adjuvant or neoadjuvant chemotherapy. Chemotherapy given concomitantly to
  radiotherapy gave significant benefits, but heterogeneity of the results
  prohibits firm conclusions. Meta-analysis of six trials (861 patients)
  comparing neoadjuvant chemotherapy plus radiotherapy with concomitant or
  alternating radiochemotherapy yielded a hazard ratio of 0·91 (0·79–1·06)
  in favour of concomitant or alternating radiochemotherapy. Three
  larynx-preservation trails (602 patients) compared radical surgery plus
  radiotherapy with neoadjuvant chemotherapy plus radiotherapy in responders or
  radical surgery and radiotherapy in non responders. The hazard ratio of death
  in the chemotherapy arm as compared with the control arm was 1·19
  (0·97–1·46). Interpretation Because the main meta-analysis showed only a
  small significant survival benefit in favour of chemotherapy, the routine use
  of chemotherapy is debatable. For larynx preservation, the non-significant
  negative effect of chemotherapy in the organ-preservation strategy indicates
  that this procedure must remain investigational.%
    }
    \verb{doi}
    \verb 10.1016/S0140-6736(00)90011-4
    \endverb
    \field{issn}{0140-6736}
    \field{number}{9208}
    \field{pages}{949\bibrangedash 955}
    \field{shortjournal}{The Lancet}
    \field{shorttitle}{Chemotherapy added to locoregional treatment for head
  and neck squamous-cell carcinoma}
    \field{title}{Chemotherapy added to locoregional treatment for head and
  neck squamous-cell carcinoma: three meta-analyses of updated individual data}
    \verb{url}
    \verb http://www.sciencedirect.com/science/article/pii/S0140673600900114
    \endverb
    \field{volume}{355}
    \field{langid}{english}
    \verb{file}
    \verb ScienceDirect Snapshot:C\:\\Users\\PatelAL\\Zotero\\storage\\XDNVEX63
    \verb \\S0140673600900114.html:text/html;ScienceDirect Full Text PDF:C\:\\U
    \verb sers\\PatelAL\\Zotero\\storage\\V5HS8A7Q\\Pignon et al. - 2000 - Chem
    \verb otherapy added to locoregional treatment for h.pdf:application/pdf
    \endverb
    \field{journaltitle}{The Lancet}
    \field{day}{18}
    \field{month}{03}
    \field{year}{2000}
    \field{urlday}{20}
    \field{urlmonth}{07}
    \field{urlyear}{2020}
  \endentry

  \entry{chalmers_science_2016}{article}{}
    \name{author}{1}{}{%
      {{hash=CA}{%
         family={Chalmers},
         familyi={C\bibinitperiod},
         given={A.J.},
         giveni={A\bibinitperiod},
      }}%
    }
    \strng{namehash}{CA1}
    \strng{fullhash}{CA1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{shorttitle}
    \verb{doi}
    \verb 10.1016/j.clon.2016.01.035
    \endverb
    \field{issn}{09366555}
    \field{number}{5}
    \field{pages}{279\bibrangedash 282}
    \field{shortjournal}{Clinical Oncology}
    \field{shorttitle}{Science in Focus}
    \field{title}{Science in Focus: Combining Radiotherapy with Inhibitors of
  the {DNA} Damage Response}
    \verb{url}
    \verb https://linkinghub.elsevier.com/retrieve/pii/S0936655516000649
    \endverb
    \field{volume}{28}
    \field{langid}{english}
    \verb{file}
    \verb Chalmers - 2016 - Science in Focus Combining Radiotherapy with Inhi.p
    \verb df:C\:\\Users\\PatelAL\\Zotero\\storage\\FLE7RAW4\\Chalmers - 2016 -
    \verb Science in Focus Combining Radiotherapy with Inhi.pdf:application/pdf
    \endverb
    \field{journaltitle}{Clinical Oncology}
    \field{month}{05}
    \field{year}{2016}
    \field{urlday}{21}
    \field{urlmonth}{07}
    \field{urlyear}{2020}
  \endentry
\enddatalist
\endinput
